Rhythm Pharmaceuticals (RYTM) PT Raised to $61 at Stifel

May 4, 2021 7:17 AM EDT
Get Alerts RYTM Hot Sheet
Price: $21.50 +3.46%

Rating Summary:
    6 Buy, 1 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 10 | Down: 9 | New: 61
Trade Now! 
Join SI Premium – FREE
Stifel analyst Derek C. Archilia raised the price target on Rhythm Pharmaceuticals (NASDAQ: RYTM) to $61.00 (from $60.00) while maintaining a Buy rating.

You May Also Be Interested In

Related Categories

Analyst PT Change